Platelet‑rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors

Huang,Guilin; Hua,Sha; Yang,Tuanmin; Ma,Jianbing; Yu,Wenxing; Chen,Xiujin

doi:10.3892/etm.2018.5794

Platelet‑rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors

Authors:
- Guilin Huang
- Sha Hua
- Tuanmin Yang
- Jianbing Ma
- Wenxing Yu
- Xiujin Chen
View Affiliations

Affiliations: Department of Orthopedics, Hong‑Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710054, P.R. China, Department of Rheumatism, Immunity Branch, Xi'an No.5 Hospital, Xi'an, Shaanxi 710082, P.R. China
Published online on: January 24, 2018 https://doi.org/10.3892/etm.2018.5794
Pages: 3096-3102

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Knee osteoarthritis is a degenerative disease that may develop due ageing, obesity, strain, congenital abnormal joints, joint deformity or trauma. It is caused by many factors, such as degradation of articular cartilage injury, joint edge and subchondral bone hyperplasia of reactivity. Platelet‑rich plasma (PRP) is an autologous blood sample that contains highly concentrated platelets and multiple cell growth factors. PRP promotes synovial cell proliferation and differentiation and may recover cartilage morphology. In the present study, the clinical efficacy of PRP was investigated in patients with knee osteoarthritis aged between 18 and 30 years in a phase‑III clinical study. Following an 8‑week baseline, patients with knee osteoarthritis were randomized into once‑weekly, double‑blind treatment with PRP (2‑14 ml) or placebo groups. The results indicated that patients with osteoarthritis treated with PRP had modulated plasma concentrations of inflammatory factors and pro‑angiogenic factors compared with the placebo group. Treatment responses were assessed by median percent reduction in inflammatory and pro‑angiogenic factors and these improved with PRP treatment compared with the placebo. Clinical data indicated that PRP alleviated knee osteoarthritis and reduced humoral and cellular immune responses that led to beneficial effects on histological parameters. Inflammation was significantly alleviated in patients receiving PRP compared with the placebo group. The most common treatment‑emergent adverse events in the presence of PRP were hypertension and proteinuria. In conclusion, treatment with PRP for patients with knee osteoarthritis presented beneficial effects in alleviating joint inflammation, cartilage destruction and bone damage, and repairing joint tissue. These results suggested that PRP may be a potential therapeutic agent for knee osteoarthritis.

View Figures

View References

1	Onuora S: Osteoarthritis: Molecular imaging detects activated macrophages. Nat Rev Rheumatol. 12:3132016. View Article : Google Scholar : PubMed/NCBI
2	Ma YW, Jiang DL, Zhang D, Wang XB and Yu XT: Radial extracorporeal shock wave therapy in a person with advanced osteonecrosis of the femoral head. Am J Phys Med Rehabil. 95:e133–e139. 2016. View Article : Google Scholar : PubMed/NCBI
3	Lee GW, Park KS, Kim DY, Lee YM, Eshnazarov KE and Yoon TR: Results of total hip arthroplasty after core decompression with tantalum rod for osteonecrosis of the femoral head. Clin Orthop Surg. 8:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
4	Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ, Eckstein F, Grago J, Boudreau RM, Englund M and Guermazi A: Partial meniscectomy is associated with increased risk of incident radiographic osteoarthritis and worsening cartilage damage in the following year. Eur Radiol. 27:404–413. 2017. View Article : Google Scholar : PubMed/NCBI
5	Tang H, He S, Zhang X, Luo S, Zhang B, Duan X, Zhang Z, Wang W, Wang Y and Sun Y: A network pharmacology approach to uncover the pharmacological mechanism of XuanHuSuo powder on osteoarthritis. Evid Based Complement Alternat Med. 2016:32469462016. View Article : Google Scholar : PubMed/NCBI
6	Poquet N, Williams M and Bennell KL: Exercise for Osteoarthritis of the Hip. Phys Ther. 96:1689–1694. 2016. View Article : Google Scholar : PubMed/NCBI
7	Maricar N, Callaghan MJ, Parkes MJ, Felson DT and O'Neill TW: Clinical assessment of effusion in knee osteoarthritis-A systematic review. Semin Arthritis Rheum. 45:556–563. 2016. View Article : Google Scholar : PubMed/NCBI
8	Beumer L, Wong J, Warden SJ, Kemp JL, Foster P and Crossley KM: Effects of exercise and manual therapy on pain associated with hip osteoarthritis: A systematic review and meta-analysis. Br J Sports Med. 50:458–463. 2016. View Article : Google Scholar : PubMed/NCBI
9	Smyth NA, Haleem AM, Ross KA, Hannon CP, Murawski CD, Do HT and Kennedy JG: Platelet-rich plasma may improve osteochondral donor site healing in a rabbit model. Cartilage. 7:104–111. 2016. View Article : Google Scholar : PubMed/NCBI
10	Fu CJ, Sun JB, Bi ZG, Wang XM and Yang CL: Evaluation of platelet-rich plasma and fibrin matrix to assist in healing and repair of rotator cuff injuries: A systematic review and meta-analysis. Clin Rehabil. 31:158–172. 2017. View Article : Google Scholar : PubMed/NCBI
11	Vannini F, Di Matteo B and Filardo G: Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: A systematic review. J Exp Orthop. 2:22015. View Article : Google Scholar : PubMed/NCBI
12	Sadabad HN, Behzadifar M, Arasteh F, Behzadifar M and Dehghan HR: Efficacy of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A systematic review and meta-analysis. Electron Physician. 8:2115–2122. 2016. View Article : Google Scholar : PubMed/NCBI
13	Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, Gandhi R, Takhar K, Lum G and Chahal J: The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: A systematic review with quantitative synthesis. Arthroscopy. 29:2037–2048. 2013. View Article : Google Scholar : PubMed/NCBI
14	Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M and Zwillich S: The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 34:318–328. 2016.PubMed/NCBI
15	van der Goes MC, Jacobs JW and Bijlsma JW: Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis. Curr Opin Rheumatol. 28:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
16	Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R and Giannini S: Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 36:e1501–e1508. 2013. View Article : Google Scholar : PubMed/NCBI
17	Laudy AB, Bakker EW, Rekers M and Moen MH: Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. Br J Sports Med. 49:657–672. 2015. View Article : Google Scholar : PubMed/NCBI
18	Meheux CJ, McCulloch PC, Lintner DM, Varner KE and Harris JD: Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: A systematic review. Arthroscopy. 32:495–505. 2016. View Article : Google Scholar : PubMed/NCBI
19	Nahler G: Karnofsky performance status. Dictionary of Pharmaceutical Medicine. 1–102. 2009. View Article : Google Scholar
20	Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M and Azma K: Knee osteoarthritis injection choices: Platelet-Rich Plasma (PRP) versus hyaluronic acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 8:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
21	Rodriguez-Merchan EC: Intraarticular Injections of Platelet-rich Plasma (PRP) in the management of knee osteoarthritis. Arch Bone Jt Surg. 1:5–8. 2013.PubMed/NCBI
22	Zalavras CG and Lieberman JR: Osteonecrosis of the femoral head: Evaluation and treatment. J Am Acad Orthop Surg. 22:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
23	Bai F, Tian H, Niu Z, Liu M, Ren G, Yu Y, Sun T1, Li S and Li D: Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. Int J Mol Med. 33:711–721. 2014. View Article : Google Scholar : PubMed/NCBI
24	Gobbi A, Lad D and Karnatzikos G: The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 23:2170–2177. 2015. View Article : Google Scholar : PubMed/NCBI
25	Filardo G, Kon E, DI Matteo B, DI Marino A, Sessa A, Merli ML and Marcacci M: Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 1:112–120. 2014.PubMed/NCBI
26	Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, et al: Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:13–47. 2000. View Article : Google Scholar : PubMed/NCBI
27	Battaglia M, Guaraldi F, Vannini F, Buscio T, Buda R, Galletti S and Giannini S: Platelet-rich plasma (PRP) intra-articular ultrasound-guided injections as a possible treatment for hip osteoarthritis: A pilot study. Clin Exp Rheumatol. 29:7542011.PubMed/NCBI
28	Jang SJ, Kim JD and Cha SS: Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 23:573–580. 2013. View Article : Google Scholar : PubMed/NCBI
29	Pierce TP, Jauregui JJ, Elmallah RK, Lavernia CJ, Mont MA and Nace J: A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 8:228–232. 2015. View Article : Google Scholar : PubMed/NCBI
30	Kilincoglu V, Yeter A, Servet E, Kangal M and Yildirim M: Short term results comparison of intraarticular platelet-rich plasma (prp) and hyaluronic acid (ha) applications in early stage of knee osteoarthritis. Int J Clin Exp Med. 8:18807–18812. 2015.PubMed/NCBI
31	Lebouvier A, Poignard A, Cavet M, Amiaud J, Leotot J, Hernigou P, Rahmouni A, Bierling P, Layrolle P, Rouard H and Chevallier N: Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: Study of their biodistribution in the early time points after injection. Stem Cell Res Ther. 6:682015. View Article : Google Scholar : PubMed/NCBI
32	Chiu WC, Lai YP and Chou MY: Humanization and characterization of an anti-human TNF-α murine monoclonal antibody. PLoS One. 6:e163732011. View Article : Google Scholar : PubMed/NCBI
33	Weisman MH: TNF and anti-TNF treatment in rheumatoid arthritis (RA). What we know and what we still need to know. Ryumachi. 37:142–143. 1997.PubMed/NCBI
34	Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J and Woody JN: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 58 2 Suppl:S92–S101. 2008. View Article : Google Scholar : PubMed/NCBI
35	Segal B, Rhodus NL and Patel K: Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 106:778–787. 2008. View Article : Google Scholar : PubMed/NCBI
36	Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N and Okamoto T: The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett. 465:23–27. 2000. View Article : Google Scholar : PubMed/NCBI
37	Görmeli G, Görmeli CA, Ataoglu B, Çolak C, Aslantürk O and Ertem K: Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 25:958–965. 2017. View Article : Google Scholar : PubMed/NCBI